Johnson Johnson J J is an American multinationalpharmaceutical biotechnology and medical technologies corporation headquartered in New Brunswick New Jersey and publicly traded on the New York Stock Exchange
Its common stock is a component of the Dow Jones Industrial Average and thecompanyis ranked No. 42 on the 2024 Fortune 500 list of the largest United States corporations. [2] In 2024 thecompanywas ranked 45th in the Forbes Global 2000
[3]Johnson Johnsonhas a global May 15 2024 Johnson Johnsonhelped make sterile surgery a reality
Since its founding in 1886 thecompanyhad by the 1890s revolutionized the field of medicine manufacturing the worlds first mass produced antiseptic medical supplies Johnson Johnsonoperates in highly competitive healthcare markets across itspharmaceuticaland medical device segments
Inpharmaceuticals thecompanycompetes with major players including Pfizer PFE Roche Novartis and Merck MRK
Thecompany s immunology franchise led by Stelara competes directly with AbbVie s ABBV Humira and Johnson Johnsonis the worlds second largest drug and biotechnologycompanyby market capitalization behind Eli Lilly LLY but ahead of other big pharma competitors such as AbbVie ABBV Novartis NVS and Merck MRK
Once known for household products like Band Aid and Tylenol its consumer brands were split off into a separatecompany Kenvue KVUE in 2023 soJohnson Johnsoncould focus on the prescription medication and biotech market
Business modelJohnson Johnson Johnson Johnson J J is one of the largest healthcare firm s in the world and one of the most diversified
Its operations are or ganized into three business segments pharmaceutical which generates 47 percent of revenues and 58 percent of operating profits medical devices and diagnostics which accounts for 36 percent of revenues an d 31 percent of operating profits and consumer which contributes 17 percent of revenues and 11 percent of operating profits
J J sp harmaceutical Johnson Johnson J J is a healthcarecompanyengaged in the research development manufacture and sale of innovative medicines and medical technologies. Thecompanyconducts business through its operating companies
It providespharmaceuticalproducts for therapy areas related to immune disorders cancer neurological disorders infectious cardiovascular and metabolic diseases and medical devices for use in cardiovascular orthopedic neurovascular care general surgery and vision 4 days ago These two acquisitions enabled thecompanyto gain a significant presence in the field ofpharmaceuticalmedicines for the first time During RobertJohnson s tenure the division for the manufacture of surgical packs and gowns became Surgikos Inc
the department for sanitary napkin production was initially called the Modess division and then became the Personal ProductsCompany birth control products were under the supervision of the OrthoPharmaceuticalCorporation and Johnson Johnsonacquires MomentaPharmaceuticals Inc
acompanythat discovers and develops novel therapies for immune mediated diseases
The acquisition will help advance patient care in auto antibody driven diseases with substantial unmet needs in maternal fetal disorders neuroimmune disorders rheumatology dermatology and autoimmune Johnson Johnson s research and development manufacturing and sale of healthcare products includepharmaceuticals medical devices and diagnostics
Thecompanyaims to improve access and create healthier communities Aug 30 2024 Johnson Johnsonand its subsidiaries theCompany have approximately 131 900 employees worldwide engaged in the research and development manufacture and sale of a broad range of products in the healthcare field Trajectory By 1937 Johnson Johnsonexpanded to countries like UK Argentina and Brazil
Thecompanywent public in the year 1944.JohnsonandJohnsonoffers wide range of products which can be categorised into three major divisions Pharmaceuticals Medical Diagnostic Devices and Consumer Products Jan 7 2025 Furthermore Johnson Johnsonhas a strong portfolio of products across thepharmaceutical medical device and consumer health segments
Thecompany spharmaceuticaldivision in particular has a diverse pipeline of innovative drugs and treatments for various medical conditions ranging from oncology to immunology Johnson JohnsonJohnson Johnsonis a multifacetedpharmaceuticaland healthcarecompanylong established as an industry leader and a widely recognized brand
Specializing in a broad array of products ranging from bandages to cutting edge drugs and medical devices by the 2020s Johnson Johnsonincluded over 260 subsidiary companies worldwide that employed more than 134 000 workers
Despite numerous product recalls and high profilelegal entanglements Johnson Johnsonhas remained one Johnson amp Johnson founded in 1886 is among the worlds largest and most influential health care companies
It is involved in the research development manufacture and distribution of Jul 1 2025 Johnson Johnsonresearches and develops.
Its common stock is a component of the Dow Jones Industrial Average and thecompanyis ranked No. 42 on the 2024 Fortune 500 list of the largest United States corporations. [2] In 2024 thecompanywas ranked 45th in the Forbes Global 2000
[3]Johnson Johnsonhas a global May 15 2024 Johnson Johnsonhelped make sterile surgery a reality
Since its founding in 1886 thecompanyhad by the 1890s revolutionized the field of medicine manufacturing the worlds first mass produced antiseptic medical supplies Johnson Johnsonoperates in highly competitive healthcare markets across itspharmaceuticaland medical device segments
Inpharmaceuticals thecompanycompetes with major players including Pfizer PFE Roche Novartis and Merck MRK
Thecompany s immunology franchise led by Stelara competes directly with AbbVie s ABBV Humira and Johnson Johnsonis the worlds second largest drug and biotechnologycompanyby market capitalization behind Eli Lilly LLY but ahead of other big pharma competitors such as AbbVie ABBV Novartis NVS and Merck MRK
Once known for household products like Band Aid and Tylenol its consumer brands were split off into a separatecompany Kenvue KVUE in 2023 soJohnson Johnsoncould focus on the prescription medication and biotech market
Business modelJohnson Johnson Johnson Johnson J J is one of the largest healthcare firm s in the world and one of the most diversified
Its operations are or ganized into three business segments pharmaceutical which generates 47 percent of revenues and 58 percent of operating profits medical devices and diagnostics which accounts for 36 percent of revenues an d 31 percent of operating profits and consumer which contributes 17 percent of revenues and 11 percent of operating profits
J J sp harmaceutical Johnson Johnson J J is a healthcarecompanyengaged in the research development manufacture and sale of innovative medicines and medical technologies. Thecompanyconducts business through its operating companies
It providespharmaceuticalproducts for therapy areas related to immune disorders cancer neurological disorders infectious cardiovascular and metabolic diseases and medical devices for use in cardiovascular orthopedic neurovascular care general surgery and vision 4 days ago These two acquisitions enabled thecompanyto gain a significant presence in the field ofpharmaceuticalmedicines for the first time During RobertJohnson s tenure the division for the manufacture of surgical packs and gowns became Surgikos Inc
the department for sanitary napkin production was initially called the Modess division and then became the Personal ProductsCompany birth control products were under the supervision of the OrthoPharmaceuticalCorporation and Johnson Johnsonacquires MomentaPharmaceuticals Inc
acompanythat discovers and develops novel therapies for immune mediated diseases
The acquisition will help advance patient care in auto antibody driven diseases with substantial unmet needs in maternal fetal disorders neuroimmune disorders rheumatology dermatology and autoimmune Johnson Johnson s research and development manufacturing and sale of healthcare products includepharmaceuticals medical devices and diagnostics
Thecompanyaims to improve access and create healthier communities Aug 30 2024 Johnson Johnsonand its subsidiaries theCompany have approximately 131 900 employees worldwide engaged in the research and development manufacture and sale of a broad range of products in the healthcare field Trajectory By 1937 Johnson Johnsonexpanded to countries like UK Argentina and Brazil
Thecompanywent public in the year 1944.JohnsonandJohnsonoffers wide range of products which can be categorised into three major divisions Pharmaceuticals Medical Diagnostic Devices and Consumer Products Jan 7 2025 Furthermore Johnson Johnsonhas a strong portfolio of products across thepharmaceutical medical device and consumer health segments
Thecompany spharmaceuticaldivision in particular has a diverse pipeline of innovative drugs and treatments for various medical conditions ranging from oncology to immunology Johnson JohnsonJohnson Johnsonis a multifacetedpharmaceuticaland healthcarecompanylong established as an industry leader and a widely recognized brand
Specializing in a broad array of products ranging from bandages to cutting edge drugs and medical devices by the 2020s Johnson Johnsonincluded over 260 subsidiary companies worldwide that employed more than 134 000 workers
Despite numerous product recalls and high profilelegal entanglements Johnson Johnsonhas remained one Johnson amp Johnson founded in 1886 is among the worlds largest and most influential health care companies
It is involved in the research development manufacture and distribution of Jul 1 2025 Johnson Johnsonresearches and develops.